Objective: The potential ability of probiotics to prepare angiotensin-converting enzyme (ACE) inhibitory fermentation broth from quinoa and the effects of fermentation process on it were investigated. Methods: In this study, 18 strains of lactic acid bacteria and 12 strains of yeast were screened for their ability to prepare ACE inhibitory fermentation broth using quinoa as the raw material and the ACE inhibition rate as an indicator. The inoculum amount, fermentation temperature and fermentation time were optimized by orthogonal tests. Finally, the peptides in the fermentation broth were identified, and the selected peptides were tested in vivo to evaluate the antihypertensive effect. Results: Lactobacillus paracasei L2 had the best effect among the 30 strains, and the ACE inhibition rate of the fermentation broth prepared by fermenting quinoa was as high as (86.50±0.25)%; The optimal fermentation conditions for the preparation of ACE inhibitory fermentation broth by fermenting quinoa with Lactobacillus paracasei L2 strain were 5% inoculum, 48 h fermentation time, and 34 ℃ fermentation temperature. Under these conditions, the ACE inhibition rate was the highest, which was (90.41±0.16)%; By comparing the results of liquid quality identification with the database, two peptides NIFRPFAPEL and AALEAPRILNL with better ACE inhibition effect were obtained. Both NIFRPFAPEL and AALEAPRILNL could significantly lower blood pressure in spontaneously hypertensive rats (SHR), and both achieved the best blood pressure lowering effect at 6 h after gavage. Systolic blood pressure (SBP) decreased by (2.67±0.21) and (3.46±0.01) kPa, and diastolic blood pressure (DBP) decreased by (29.36±0.54) and (22.33±0.77) kPa, respectively. And NIFRPFAPEL and AALEAPRI-LNL had no effect on blood pressure in Wistar-Kyoto rats (WKY). Conclusion: Therefore, quinoa is a high-quality grain raw material for preparing ACE inhibitory fermentation broth, and NIFRPFAPEL and AALEAPRILNL can be used for the development of blood pressure-lowering functional foods or medicines.

Publication Date


First Page


Last Page





[1] 王增武,杨瑛,王文,等.我国高血压流行新特征:中国高血压调查的亮点和启示[J].中国循环杂志,2018,33(10):937-939.WANG Z W,YANG Y,WANG W,et al.New characteristics of hypertension epidemic in China:Highlights and enlightenment of hypertension survey in China[J].Chinese Circulation Journal,2018,33(10):937-939.
[2] 陈冰冰,欧颖仪,叶灏铎,等.富硒辣木叶蛋白ACE抑制肽的酶解工艺优化及活性研究[J].食品工业科技,2022,43(3):1-9.CHEN B B,OU Y Y,YE H D,et al.Optimization of enzymatic hydrolysis process and activity of ACE inhibitory peptides from selenium-rich moringa oleifera leaves protein[J].Science and Technology of Food Industry,2022,43(3):1-9.
[3] WU J J,XIE D W,CHEN X J,et al.Inhibitory mechanism of a substrate-type angiotensin I-converting enzyme inhibitory peptide[J].Process Biochemistry,2019,79:97-104.
[4] ERDS E G,JACKMAN H L,BROVKOVYCH V,et al.Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin[J].Journal of Molecular and Cellular Cardiology,2002,34(12):1 569-1 576.
[5] PACURARI M,KAFOURY R,TCHOUNWOU P B,et al.The renin-angiotensin-aldosterone system in vascular inflammation and remodeling[J].International Journal of Inflammation,2014,2 014:689360.
[6] DENG Z Z,LIU Y J,WANG J,et al.Antihypertensive effects of two novel angiotensin I-converting enzyme(ACE)inhibitory peptides from Gracilariopsis lemaneiformis(Rhodophyta)in spontaneously hypertensive rats(SHRs)[J].Marine drugs,2018,16(9):299.
[7] XIE J L,CHEN X J,WU J J,et al.Antihypertensive effects,molecular docking study,and isothermal titration calorimetry assay of angiotensin I-converting enzyme inhibitory peptides from Chlorella vulgaris[J].Journal of Agricultural and Food Chemistry,2018,66(6):1 359-1 368.
[8] CUI P F,YANG X,LI Y L,et al.The milk macromolecular peptide:Preparation and evaluation of antihypertensive activity in rats[J].Food & Function,2020,11(5):4 403-4 415.
[9] CHOE J,SEOL K H,KIM H J,et al.Isolation and identification of angiotensin I-converting enzyme inhibitory peptides derived from thermolysin-injected beef M.longissimus[J].Asian-Australasian Journal of Animal Sciences,2019,32(3):430-436.
[10] ZHANG B Y,LIU J B,LIU C,et al.Bifunctional peptides with antioxidant and angiotensin-converting enzyme inhibitory activity in vitro from egg white hydrolysates[J].Journal of Food Biochemistry,2020,44(9):e13347.
[11] 章禹航,翟雨,韩玥颖,等.鲅鱼加工副产物水解液中ACE抑制肽分离纯化研究[J].农产品加工,2021(13):6-8,16.ZHANG Y H,ZHAI Y,HAN Y Y,et al.Study on isolation and purification of ace inhibitory peptides from spanish mackerel processing by products hydrolysate[J].Farm Products Processing,2021(13):6-8,16.
[12] KARAMI Z,PEIGHAMBARDOUST S H,HESARI J,et al.Identification and synthesis of multifunctional peptides from wheat germ hydrolysate fractions obtained by proteinase K digestion[J].Journal of Food Biochemistry,2019,43(4):e12800.
[13] FSTE M,ELGETI D,BRUNNER A K,et al.Isolation of quinoa protein by milling fractionation and solvent extraction[J].Food and Bioproducts Processing,2015,96:20-26.
[14] NAVRUZ-VARLI S,SANLIER N.Nutritional and health benefits of quinoa(Chenopodium quinoa Willd.)[J].Journal of Cereal Science,2016,69:371-376.
[15] 刘雪,宋菁景,林小晖.藜麦营养和生物活性成分研究进展[J].食品安全导刊,2022(7):135-137.LIU X,SONG J J,LIN X H.Research progress on nutrition and bioactive components of Chenopodium quinoa Willd.[J].China Food Safety,2022(7):135-137.
[16] 王天,江含秀,路丽妮,等.藜麦可溶性膳食纤维提取工艺优化及其抗氧化活性研究[J].中国食品添加剂,2022,33(2):137-146.WANG T,JIANG H X,LU L N,et al.Optimization of extraction process of quinoa soluble dietary fiber and its antioxidant activity[J].China Food Additives,2022,33(2):137-146.
[17] VILCACUNDO R,MARTNEZ-VILLALUENGA C,HERN-NDEZ-LEDESMA B.Release of dipeptidyl peptidase IV,α-amylase and α-glucosidase inhibitory peptides from quinoa(Chenopodium quinoa Willd.)during in vitro simulated gastrointestinal digestion[J].Journal of Functional Foods,2017,35:531-539.
[18] VILCACUNDO R,MIRALLES B,CARRILLO W,et al.In vitro chemopreventive properties of peptides released from quinoa(Chenopodium quinoa Willd.)protein under simulated gastrointestinal digestion[J].Food Research International,2018,105:403-411.
[19] MUDGIL P,KILARI B P,KAMAL H,et al.Multifunctional bioactive peptides derived from quinoa protein hydrolysates:Inhibition of α-glucosidase,dipeptidyl peptidase-IV and angiotensin I converting enzymes[J].Journal of Cereal Science,2020,96:103130.
[20] NONGONIERMA A B,LE MAUX S,DUBRULLE C,et al.Quinoa(Chenopodium quinoa Willd.)protein hydrolysates with in vitro dipeptidyl peptidase IV(DPP-IV)inhibitory and antioxidant properties[J].Journal of Cereal Science,2015,65:112-118.
[21] 王姣琳,岳田利,袁亚宏.红曲霉与乳酸菌混合发酵藜麦制备降压肽[J].食品与发酵工业,2021,47(21):217-224.WANG J L,YUE T L,YUAN Y H.The preparation of antihypertensive peptides from quinoa by mixed fermentation with monascus and lactic acid bacteria[J].Food and Fermentation Industries,2021,47(21):217-224.
[22] HAJFATHALIAN M,GHELICHI S,GARCA-MORENO P J,et al.Peptides:Production,bioactivity,functionality,and applications[J].Critical Reviews in Food Science and Nutrition,2018,58(18):3 097-3 129.
[23] CRUZ-CASAS D E,AGUILAR C N,ASCACIO-VALDS J A,et al.Enzymatic hydrolysis and microbial fermentation:The most favorable biotechnological methods for the release of bioactive peptides[J].Food Chemistry:Molecular Sciences,2021,3:100047.
[24] AYYASH M,JOHNSON S K,LIU S Q,et al.Cytotoxicity,antihypertensive,antidiabetic and antioxidant activities of solid-state fermented lupin,quinoa and wheat by Bifidobacterium species:In-vitro investigations[J].LWT-Food Science and Technology,2018,95:295-302.
[25] AYYASH M,JOHNSON S K,LIU S Q,et al.In vitro investigation of bioactivities of solid-state fermented lupin,quinoa and wheat using Lactobacillus spp[J].Food Chemistry,2019,275:50-58.
[26] KLUPSAITE D,JUODEIKIENE G,ZADEIKE D,et al.The influence of lactic acid fermentation on functional properties of narrow-leaved lupine protein as functional additive for higher value wheat bread[J].LWT-Food Science and Technology,2017,75:180-186.
[27] ZHENG Y J,WANG X,ZHUANG Y L,et al.Isolation of novel ACE-Inhibitory and antioxidant peptides from quinoa bran albumin assisted with an in silico approach:Characterization,in vivo antihypertension,and molecular docking[J].Molecules,2019,24(24):4 562.



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.